Related Experiment Videos
[Prenatal growth of children of epileptic mothers]
Psychiatrie, Neurologie, Und Medizinische Psychologie
|February 1, 1986
Insights
Children born to mothers with epilepsy on Primidon medication showed lower birth weight and smaller head circumference. This highlights potential developmental impacts of anticonvulsant use during pregnancy.
Area of Science:
- Neurology
- Developmental Pediatrics
- Pharmacology
Context:
- Epilepsy affects numerous women of childbearing age.
- Anticonvulsant medications are frequently prescribed during pregnancy.
- Primidone is an anticonvulsant used to manage epilepsy.
Purpose:
- To investigate the impact of maternal epilepsy and anticonvulsant medication, specifically Primidone, on offspring development.
- To compare developmental outcomes (weight, head circumference) in children exposed to Primidone versus other conditions.
Summary:
- This study examined 67 children born to 59 mothers with epilepsy.
- Offspring of mothers on Primidone medication exhibited significantly lower weight and smaller head circumference compared to children of epileptic mothers not on medication and children from non-epileptic parents.
- Findings suggest Primidone exposure may be associated with reduced fetal growth.
Impact:
- Highlights potential risks associated with Primidone use in pregnant women with epilepsy.
- Informs clinical practice regarding medication choices and monitoring during pregnancy for women with epilepsy.
- Suggests the need for further research into the specific mechanisms underlying Primidone's effect on fetal development.
Abstract:
In this study 67 children of 59 females with epilepsy and on anticonvulsants were investigated. Children of epileptic women on medication with Primidon are of lower weight and have smaller heads than children from epileptic mothers without medication and children from parents without epilepsy.